14 December 2018
Tips & tricks, traps to avoid, Q/A's, insights from reviewers: we have put together a programme to give you the best advice and get you off to a good start for your abstract submission for ESHRE 2019. The deadline for submitting abstracts is 1 February 2019. More information and submitting via this link. You can download the presentation in pdf format right here.
13 December 2018
On 5-6 December 2018 in Geneva, WHO organized the first ever Global Summit on Safety and Access to Fertility Care aimed at developing strategies for improving access to safe, ethical, and cost-effective fertility care in low to middle income countries (LMIC). The main objective was to focus on the needs of over 40 LMIC in delivering global access to fertility care services as a strategic priority and identifying goals that universally promote healthy lives and well-being for all. In particular, the meeting consensus identified health system strengthening, appropriate HR resource and training as high priorities.
The summit gathered a number of experts from professional societies, industry, academia, government, and patient advocacy to assess the current situation of fertility care in LMIC with special attention to the challenge of providing fertility investigation at affordable costs, implementing effective interventions with minimal harm in a safe and controlled manner to ensure high standard provision.
It was emphasized again that infertility is a disease, and for this reason, it is important to develop strategies for its inclusion in the national health care agendas and international classifications of diseases. In addition, there was general consensus regarding the need of data collection and management, guidelines, and education at all levels.
ESHRE contributed to this event from its inception as co-sponsors and committed support for speakers and delegates in the belief that the summit was a milestone towards the design of a common strategy to assist those millions of couples needing medical assistance to fulfil their child wish and create a family.
22 October 2018
ESHRE has collaborated in the creation of the now published brochure “Donation of Oocytes - a guide for women to support informed decisions”, issued by the Council of Europe.
It is important to make this guide as accessible as possible to patients across Europe and ESHRE therefore wants to encourage national societies within reproductive care to translate the publication into their national language.
If your organisation would be willing to translate the guide, please note that it is important to first seek permission with the Council of Europe who holds the copyright of the publication. This can be done by sending an e-mail to email@example.com where you will have to specify your intention and the language of translation. Permission is formalised by a written agreement between your organisation and the Council of Europe.
7 August 2018
A 324-page monograph published by Fertility and Sterility to mark the 40-year history of IVF contains a chapter on ESHRE's part in reproductive medicine's inexorable advance. The chapter goes back to ESHRE's origins and the drive of Robert Edwards to establish the Society and its journals, and on to today, when both the annual meeting (which in 2018 attracted more than 12,000 participants) and the journals (of which Human Reproduction Update has just achieved an unprecedented impact factor of 11.9) have consolidated ESHRE as a reference point in reproductive science and medicine. The monograph, whose authors represent an A-list of authorities from the past 40 years of progress, can be found at https://www.fertstert.org/current
20 April 2018
ESHRE shares the sadness of so many others in learning of the untimely death of John Biggers, Professor Emeritus of Harvard Medical School, USA. John was born and trained in England, where in 1958 he and Anne McLaren published their landmark paper in Nature describing the first successful culture of an early mammalian (mouse) embryo, which would lay the foundations of successful IVF 20 years later, and indeed of modern clinical embryology. John moved to the USA the following year and finally in 1972 to Harvard Medical School as Professor of Physiology. He leaves behind a wealth of research and clinical publications, notably in early mammalian embryos and their nutritional requirements for blastocyst formation. In 1978 he headed an ethics advisory committee appointed by President Carter to decide whether US public funds could be used for research in human IVF. John's place will remain a landmark in the history of IVF and his inspiration is acknowledged by all of us at ESHRE.
16 April 2018